BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15160285)

  • 1. Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome.
    Tanaka H; Nakahata T; Ito E
    Pediatr Nephrol; 2004 Sep; 19(9):1055-8. PubMed ID: 15160285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
    Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
    Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.
    Suzuki K; Oki E; Tsuruga K; Aizawa-Yashiro T; Ito E; Tanaka H
    Tohoku J Exp Med; 2010 Mar; 220(3):183-6. PubMed ID: 20208412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
    Fujinaga S; Ohtomo Y; Someya T; Shimizu T; Yamashiro Y; Kaneko K
    Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood.
    Neuhaus TJ; Burger HR; Klingler M; Fanconi A; Leumann EP
    Eur J Pediatr; 1992 Oct; 151(10):775-8. PubMed ID: 1425802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
    Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Hamed RM
    J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS; Sorof JM; Brewer ED; Kale AS
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
    Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal biopsy findings in children receiving long-term treatment with cyclosporine a given as a single daily dose.
    Tanaka H; Tsugawa K; Suzuki K; Ito E
    Tohoku J Exp Med; 2006 Jul; 209(3):191-6. PubMed ID: 16778365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
    El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Sheashaa H; Sabry A; Hassan N; Sayed-Ahmad N; Sobh M
    Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
    Ohtomo Y; Fujinaga S; Takada M; Murakami H; Akashi S; Shimizu T; Kaneko K; Yamashiro Y
    Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.
    Hamasaki Y; Komaki F; Ishikura K; Hamada R; Sakai T; Hataya H; Ogata K; Ando T; Honda M
    Pediatr Nephrol; 2017 Aug; 32(8):1383-1390. PubMed ID: 28378029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
    Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
    Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.